impact dashboard - september 2018

Transcription

1 impact dashboard - september 2018 PSI 2015 As of, PSI averted an estimated 17.1 M DALYs, provided 12.5 M CYPs, and reached 18.4 M users globally. Globally PSI has reached at least 18.4 million users across the five health areas in 2018: 7.6 M with malaria tests; 7.6 M with modern contraception; 2.3 M with HIV testing, 737,000 with NCD screening; and 173,000 with toilets. PSI safe abortion work in 18 countries has reached 1.3 million women and achieved an estimated 1.2 million completed abortions in PSI has reached 7.6 million women with modern contraception and provided 12.5 million CYPs in Overall, PSI is behind the YTD 2018 program targets for CYPs which should be at 75%: 66%, 70%, 86%, and 110% of the targets. Among the top 15 CYP producers, India LLC, Malawi, and South need to boost their CYP performance the rest of the year to meet the annual targets. Service provision provided ~5 million CYPs in The CYP ratio for product distribution to service provision is also shifted from 70:30 last year to 60:40 this year. PSI PROGRESS ON HEALTH IMPACT % Change from 2018 Program % 2018 Program Target SP Target % SP Target Time Elapsed DALYs 1,871,629 17,104,714-20% 22,503,745 76% 100,000,000 17% 25% CYPs Provided 1,674,827 12,543,135-16% 17,207,079 73% 75,000,000 17% (9/36 months) Users Reached # 1,599,234 18,431,481-8% 16,608, % 90,000,000 20% # The sum of clients who receive modern contraception, testing for HIV (among high risk), testing for malaria, NCD screening, or toilets from PSI. PSI PROGRESS IN DALYS AVERTED, CYPS PROVIDED, AND USERS REACHED # Target: 25% increase in DALYs averted relative to DALYs by Region CYPs Provided by Region Southern 40% East 32% West & Central 19% Latin America & Caribbean 1% Asia & Eastern Europe 8% Latin America & Caribbean 6% Southern 16% Asia & Eastern Europe 36% East 28% West & Central 14% Users Reached # by Region Latin America & Caribbean 4% Asia & Eastern Europe 27% Southern 33% East West & Central 9% PSI REGIONAL AND HEALTH AREA PERFORMANCE Region DALYs YTD % of 2018 Program CYPs Provided YTD % of 2018 Program West & Central 169,752 3,182,896-58% 83% 211,666 1,725,484-55% 103% East 831,953 5,408,462-4% 69% 601,904 3,475,288-14% 77% Southern 678,330 6,800,721 6% 82% 218,726 2,050,306 8% 80% Latin America & Caribbean 19, ,238 29% 107% 71, ,291 47% 101% Asia & Eastern Europe 172,553 1,469,398-6% 65% 570,643 4,580,767-4% 59% TOTAL 1,871,629 17,104,714-20% 76% 1,674,827 12,543,135-16% 73% Health Area DALYs Users Reached # Users Reached # YTD % of 2018 Program Testing for Malaria 360,531 7,622,635 2% 252% Modern Contraception 906,877 7,559,880-21% 73% Testing for HIV 244,196 2,338,392 23% 92% NCD Screening 49, ,060 36% 170% Toilets Sold 37, ,514-72% 77% TOTAL 1,599,234 18,431,481-8% 111% CYPs Provided Modern Contraception 41% Testing for HIV 13% Users Reached # by Health Area Testing for Malaria 41% NCD Screening 4% Toilets Sold 0.9% IMPACT DASHBOARD - SEPTEMBER

2 COUNTRIES BY YTD 2018 DALYS AVERTED 100% DALYs % of DALYs % DALYs Mali 16,541 2,060,021-20% 2,827,378 73% 2,060, % Zimbabwe 234,452 1,703,758 26% 1,998,944 85% 1,703, % South 147,585 1,447,080-18% 2,668,799 54% 1,447, % Kenya 245,585 1,427,169 28% 1,847,212 77% 1,427, % Madagascar 36,531 1,380,119 75% 1,096, % 1,380, % South Sudan 146,646 1,177,053-21% 2,286,907 51% 1,177, % Uganda 216, ,329 17% 1,200,788 81% 975, % Malawi 62, ,484-12% 948,879 83% 788, % Angola 142, ,077 0% 785,540 79% 620, % Swaziland 51, ,802 10% 885,727 69% 610, % Tanzania 103, ,496-38% 921,192 65% 600, % Pakistan 57, ,348-24% 398, % 478, % Lesotho 3, , % 139, % 447, % India LLC 59, ,336 36% 1,073,307 38% 403, % Nigeria 40, ,267-86% 96, % 393, % Cameroon 21, ,359 31% 423,028 71% 301, % Mozambique 45, ,280-16% 437,315 67% 293, % Zambia 12, ,879-62% 271, % 284, % Benin 76, ,313 14% 285,082 77% 220, % Myanmar 20, ,202-10% 317,691 65% 205, % Ethiopia 31, , % 201,948 98% 198, % Cambodia 16, ,746 10% 191,608 80% 153, % India 9, ,871 10% 146,584 97% 142, % Haiti 6, ,847 37% 107, % 129, % Burundi 21, ,583 5% 153,525 73% 111, % Rwanda 0 104,356-23% 244,226 43% 104, % Ghana 4,200 93,468-38% 88, % 93, % Senegal 6,940 57,964 91% 63,626 91% 57, % Guatemala 6,336 52,597 82% 33, % 52, % Niger 3,189 38,625 75% 36, % 38, % Nepal 2,862 31,571 31% 40,232 78% 31, % Somaliland 3,747 25,579 6% 46,705 55% 25, % Viet Nam 4,056 20,867-1% 40,972 51% 20, % Laos 2,457 18,537 19% 35,465 52% 18, % Paraguay 1,597 15,454-3% 22,628 68% 15, % Honduras 1,428 14,728 15% 15,924 92% 14, % Botswana 3,401 11,930-30% 20,439 58% 11, % Tajikistan 94 11,700-8% 10, % 11, % Dominican Republic 1,707 11,037-26% 19,020 58% 11, % Cote d'ivoire 513 9, % 11,162 83% 9, % Nicaragua 905 8,400-13% 12,449 67% 8, % Liberia 426 7,452 54% 13,866 54% 7, % El Salvador 322 5,495-6% 8,414 65% 5, % Panama 214 4,070 0% 6,012 68% 4, % Papua New Guinea 0 2,062-97% 2,270 91% 2, % Costa Rica 159 1,610 15% 1,940 83% 1, % Namibia 586 1,453-58% 16,305 9% 1, % Guinea 0 1,194-99% NA NA 1, % Kazakhstan % % % Kyrgyzstan % % % PSI GLOBAL 1,871,629 17,104,714-20% 22,503,745 76% 17,104, % PSI South ** 75, ,936-31% 1,013,490 47% 471, % **included sales / distribution in Botswana, Lesotho, Namibia, South, Swaziland, and Zambia. These sales / distribution are also included in the countries above. - IMPACT DASHBOARD - SEPTEMBER

3 PSI PRODUCTS & SERVICES BY YTD 2018 DALYS AVERTED 100% 0% Products / Services DALYs % of # Distributed Reporting 2018 CYPs Condom 359,073 2,936,132-28% 64% 345,575, ,879,795 Free Condom 248,279 2,436,895 4% 82% 127,109, ,059,248 Voluntary Medical Male Circumcision 266,045 2,292,594 6% 81% 349,749 6 Malaria PPT (ACT) 49,751 2,118,448-49% 89% 6,682,320 8 LLIN 203,147 1,780,547-18% 54% 11,048, IUD Insertion 145,958 1,326,305 3% 91% 542, ,373,882 Implant Insertion 157,012 1,111,199 16% 131% 532, ,694,098 Seasonal Malaria Chemoprevention 0 521,220-31% 100% 1,665,225 1 Pneumonia PPT 97, ,558 73% 99% 602,467 4 IUD Distribution 110, ,812-23% 41% 222, ,208 Injectable Contraception Dist. 26, ,955-56% 102% 4,654, ,135,909 OCs 27, ,290-48% 79% 19,434, ,295,628 TB DOTS 18, ,489 25% 186% 47,323 5 Tubal Ligation 18, ,838 32% 97% 50, ,383 Medical Abortion 11, ,832 95% 80% 1,146,246 4 Misoprostol for Safe Abortion 9,341 97, % 74% 4,125, Injectable Contraception Provided 11,531 90,629 28% 154% 1,222, ,684 ORS 4,777 78,745 49% 72% 2,678,348 4 Antiretroviral Treatment 9,840 64,715 0% 304% 370, HIV Testing Services 3,983 55,610-30% 66% 1,922, Diarrhea Treatment Kit 23,080 46,210-52% 67% 540,089 5 Needle & Syringe 4,027 27,121-27% 59% 3,447,415 2 OCs Provided 3,182 25,652 7% 97% 1,127, ,158 Safe Water Solution 1,075 24,049-25% 61% 4,661,200 9 Skilled Birth Attendance 2,450 23,169-42% 169% 23,562 2 Female/Woman Condom ,718-11% 30% 1,012, ,436 Free Female Condom 3,602 15,111-23% 96% 831, ,926 Referral 1,524 14,874-16% 41% 18, ,500 Implant Distribution 42,094 14,103-95% 5% 21, ,795 QAACTs Provided after Confirmatory Diagno 1,762 13, % 1058% 82,804 5 Misoprostol for PAC Provided 940 8,664 84% 97% 52, Emergency Contraception 581 8,654-62% 53% 2,102, ,128 Pneumonia PPT Provided 848 7,879-91% 40% 16,381 1 Chlorhexidine 60 7,012-37% 243% 114,753 2 Water Treatment Tablets 661 6,204-25% 57% 28,475, Toilets Sold 1,505 5,951-71% 85% 36,580 6 Zinc 625 5,615-81% 124% 501,946 2 Manual Vacuum Aspiration for PAC 555 4,915 49% 146% 37, IPTp2 17 4,765 63% 35% 80,890 2 SDM (Cycle Beads) 680 3,569-87% 241% 5, ,706 Clean Delivery Kit 309 3,442 2% 71% 27,917 1 Naloxone 0 2,729-10% 1000% 2,000 1 PUR 243 2,421-3% 106% 58,139,854 6 IUS Distribution 11 2, % 20% 1, ,341 IUS Insertion 166 1,448 4% 217% ,081 Vasectomy 99 1,346-80% 36% ,772 STI Treatment 177 1,301-24% 256% 19,132 7 Medical Abortion Provided 111 1,049 73% 170% 9,752 4 Diarrhea Treatment Kit Provided % NA 15,087 2 Multivitamin % 52% 1,900,300 2 Fecal Sludge Management % 36% Vivax Treatment after Confirmatory Diagnosi % 36% 2,323 2 SDM (Cycle Beads) Provided % 41% Cervical Cancer Treatment % 33% 1,022 8 Manual Vacuum Aspiration for SA NA 35% STI Kit % 34% 3,555 1 Medical Abortion (Misoprostol) Provided NA NA PrEP % 11% 3,954 3 Misoprostol for PPH % 66% 19,800 1 Emergency Contraception Provided % 13% 15, ORS Provided % NA 1,636 1 Treatment for Pre-Eclampsia (with MgSO4) % 110% 43 1 Zika Prevention Kit % 114% Malaria PPT (Non-ACT) % -1% -1,053 1 HIV Self-Testing Kit NA NA NA NA 461,910 3 IRS (# of household) NA NA NA NA 0 0 Malaria RDK NA NA NA NA 7,612,722 8 Micronutrient Powder NA NA NA NA 6,754,259 3 Treatment for Severe Acute Malnutrition % 0% 0 0 PSI GLOBAL 1,871,629 17,104,714-20% 76% 12,543,135 IMPACT DASHBOARD - SEPTEMBER

4 YTD 2018 CASES AND DEATHS AVERTED BY PRODUCTS & SERVICES Products / Services DALYs Deaths HIV Cases Maternal Deaths Unintended Pregnancies # Distributed Condom 359,073 2,936,132 57, , ,575,353 Free Condom 248,279 2,436,895 54, , ,109,789 Voluntary Medical Male Circumcision 266,045 2,292,594 41, ,749 Malaria PPT (ACT) 49,751 2,118,448 24,701 6,682,320 LLIN 203,147 1,780,547 22,424 11,048,701 IUD Insertion 145,958 1,326,305 1, , ,653 Implant Insertion 157,012 1,111,199 1, , ,887 Seasonal Malaria Chemoprevention 0 521,220 6,047 1,665,225 Pneumonia PPT 97, ,558 5, ,467 IUD Distribution 110, , , ,441 Injectable Contraception Dist. 26, , ,711 4,654,303 OCs 27, , ,001 19,434,413 TB DOTS 18, ,489 3,948 47,323 Tubal Ligation 18, , ,750 50,920 Medical Abortion 11, ,832 1,886 1,146,246 Misoprostol for Safe Abortion 9,341 97,147 1,722 4,125,002 Injectable Contraception Provided 11,531 90, ,028 1,222,641 ORS 4,777 78, ,678,348 Antiretroviral Treatment 9,840 64,715 1, ,379 HIV Testing Services 3,983 55,610 1,385 1,922,422 Diarrhea Treatment Kit 23,080 46, ,089 Needle & Syringe 4,027 27,121 3,447,415 OCs Provided 3,182 25, ,079 1,127,368 Safe Water Solution 1,075 24, ,661,200 Skilled Birth Attendance 2,450 23, ,562 Female/Woman Condom , ,012,295 Free Female Condom 3,602 15, ,141 Referral 1,524 14,874 1, ,721 Implant Distribution 42,094 14, ,242 21,915 QAACTs Provided after Confirmatory Diagno 1,762 13, ,804 Misoprostol for PAC Provided 940 8, ,781 Emergency Contraception 581 8, ,462 2,102,557 Pneumonia PPT Provided 848 7, ,381 Chlorhexidine 60 7, ,753 Water Treatment Tablets 661 6, ,475,102 Toilets Sold 1,505 5, ,580 Zinc 625 5, ,946 Manual Vacuum Aspiration for PAC 555 4, ,412 IPTp2 17 4, ,890 SDM (Cycle Beads) 680 3, ,747 5,137 Clean Delivery Kit 309 3, ,917 Naloxone 0 2, ,000 PUR 243 2, ,139,854 IUS Distribution 11 2, ,082 1,030 IUS Insertion 166 1, Vasectomy 99 1, , STI Treatment 177 1, ,132 Medical Abortion Provided 111 1, ,752 Diarrhea Treatment Kit Provided ,087 Multivitamin ,900,300 Fecal Sludge Management Vivax Treatment after Confirmatory Diagnosi ,323 SDM (Cycle Beads) Provided Cervical Cancer Treatment ,022 Manual Vacuum Aspiration for SA STI Kit ,555 Medical Abortion (Misoprostol) Provided PrEP ,954 Misoprostol for PPH ,800 Emergency Contraception Provided ,279 ORS Provided ,636 Treatment for Pre-Eclampsia (with MgSO4) Zika Prevention Kit Malaria PPT (Non-ACT) ,053 HIV Self-Testing Kit NA NA 461,910 IRS (# of household) NA NA 0 Malaria RDK NA NA 7,612,722 Micronutrient Powder NA NA 6,754,259 Treatment for Severe Acute Malnutrition PSI GLOBAL 1,871,629 17,104,714 70, ,034 6,448 3,200,915 IMPACT DASHBOARD - SEPTEMBER

5 COUNTRIES BY YTD 2018 CYPS PROVIDED 100% 2018 CYPs CYPs % of 2018 CYPs FP Method Mix** CYPs Provided % of CYPs Provided Pakistan 218,157 1,714,369-23% 93% 1,714, % Uganda 278,478 1,230,046 18% 83% 1,230, % India LLC 211,839 1,162,424 23% 31% 1,162, % Madagascar 92, ,047 17% 92% 804, % Kenya 173, ,231-9% 75% 752, % Tanzania 60, ,472-44% 75% 694, % Cambodia 61, ,589 7% 77% 561, % India 32, ,465 41% 97% 507, % Malawi 43, ,205-32% 68% 505, % Myanmar 34, ,637-13% 75% 437, % South 28, ,766-37% 51% 369, % Guatemala 42, , % 184% 363, % Cameroon 24, ,101 35% 75% 355, % Nigeria 37, ,139-80% NA 337, % Ghana 14, ,914-37% 109% 336, % Benin 101, ,708 9% 69% 310, % Mali 17, ,070 58% 81% 235, % Mozambique 32, ,044 16% 76% 226, % Ethiopia 26, , % 101% 170, % Zambia 18, , % 150% 163, % Zimbabwe 21, ,795 1% 65% 144, % Lesotho , % 567% 119, % Swaziland 9, ,309 15% 70% 112, % Angola 12, , % 72% 102, % Nepal ,500 9% 78% 99, % Laos 11,765 88,404 15% 50% 88, % Senegal 10,492 78,580 95% 89% 78, % Rwanda 0 69,655-20% 47% 69, % Haiti , % 68% 67, % Paraguay 6,810 65,645 3% 71% 65, % Nicaragua 5,829 53,912-5% 77% 53, % Dominican Republic 8,319 53,078-28% 57% 53, % Burundi 18,555 50,281 37% 73% 50, % El Salvador 3,126 46,012-4% 61% 46, % Niger 3,733 44,915 85% 108% 44, % Honduras 2,863 30,046 17% 82% 30, % Panama 1,000 19,430 0% 67% 19, % Cote d'ivoire , % 103% 13, % Costa Rica 1,160 11,737 15% 83% 11, % Liberia ,231 60% 53% 10, % Botswana 1,987 6,971-30% 58% 6, % Viet Nam 354 4, % 126% 4, % Tajikistan 75 3,800 99% 285% 3, % Guinea 0 2,879-98% NA 2, % Somaliland 301 2, % 79% 2, % Namibia % 9% % Papua New Guinea % 9% % Kazakhstan % 227% % Kyrgyzstan NA 31% % South Sudan 0 0 NA NA 0 0.0% PSI GLOBAL 1,674,827 12,543,135-16% 73% 12,543,135 ** # of long-term methods including implants, IUDs and male/female sterilization; # of short-term methods including male condom, female condom, cycle beads, EC, injectables and OC PSI South ** 30, ,046-30% 48% 186, % ***included sales / distribution in Botswana, Lesotho, Namibia, South, Swaziland, and Zambia. These sales / distribution are also included in the countries above. IMPACT DASHBOARD - SEPTEMBER

6 COUNTRIES BY YTD 2018 USERS REACHED # 100% Modern Contraception Testing for HIV Users Reached # % of 2018 Users Reached Program Testing for NCD Screening Toilets TOTAL Malaria Madagascar 641, ,899 3,456, ,264, % South Sudan 2,566,213 2,566, % Myanmar 386,021 35, , ,265 1,535,309 89% Pakistan 1,133,839 1,133,839 88% India LLC 810, ,033 36% Kenya 562, ,368 23, ,140 78% Cambodia 383, , ,554 90% Nigeria 77, , ,873 NA South 332, , ,693 62% Malawi 265, ,916 15, , % Uganda 391,958 53, ,180 93% Ethiopia 153, ,600 15, ,422 94% Viet Nam 1,540 6,054 24, ,018 11, , % Zambia 96, , ,451 62% Haiti 57, , , ,083 81% Ghana 303, , % Tanzania 301, ,504 82% Zimbabwe 119,282 33, , , % Lesotho 107, ,425 2, ,500 44% India 73, , ,143 87% Cameroon 193,955 8, ,199 69% Guatemala 193,418 1, , % Benin 112,165 40,171 33,436 9, ,347 84% Mozambique 141, ,152 72% Angola 44,054 89, ,964 47% Swaziland 100,931 29,490 2, ,180 50% Dominican Republic 47,770 31,033 78,803 64% Laos 43,269 4,058 29,090 76,417 68% Mali 65,089 9,686 74,775 82% Senegal 70, ,564 77% Rwanda 62,689 62,689 47% Burundi 40,996 18,437 59,433 77% Paraguay 59,080 59,080 71% Niger 22,517 12,745 35, % Nicaragua 29, ,682 62% Honduras 26,662 2,458 29,120 89% El Salvador 24,233 2, ,559 65% Nepal 22,946 22,946 83% Cote d'ivoire 7,707 12, ,632 66% Kyrgyzstan ,951 19, % Panama 17,487 1,123 18,610 66% Tajikistan 3,420 13,033 16, % Liberia 9,207 5,773 14,980 58% Costa Rica 10,563 10,563 83% Botswana 6,274 6,274 58% Papua New Guinea 468 4,022 4,490 88% Guinea 2,591 2,591 NA Kazakhstan 409 1,796 2,205 81% Somaliland 2,122 2, % Namibia % PSI GLOBAL 7,559,880 2,338,392 7,622, , ,514 18,431, % # The sum of clients who receive modern contraception, testing for HIV (among high risk), testing for malaria, NCD screening, and toilets from PSI. PSI South ** 167, ,442 48% ***included sales / distribution in Botswana, Lesotho, Namibia, South, Swaziland, and Zambia. These sales / distribution are also included in the countries above. IMPACT DASHBOARD - SEPTEMBER

7 PSI PROGRESS ON SAFE ABORTION, Product Distribution and Service Provision # Distributed / Safe Abortion Users Completed DALYs # Service Reached Abortions :: Product Distribution 1,248,184 1,164, ,979 Medical Abortion 1,146,246 1,031, , ,832 1,429,599 80% Misoprostol for Safe Abortion 4,125, , ,078 97,147 5,238,648 79% :: Service Provision 101,236 91,068 15,054 Manual Vacuum Aspiration for PAC 37,412 37,412 29,930 4,915 15, % Manual Vacuum Aspiration for SA ,854 41% Medical Abortion (Misoprostol) Provided Medical Abortion Provided 9,752 9,752 9,264 1,049 4, % Misoprostol for PAC Provided 52,781 52,781 50,670 8,664 19, % Total 1,349,420 1,255, ,034 PSI PROGRESS ON SERVICE PROVISION AND REFERRAL, :: CYPs and DALYs from FAMILY PLANNING SERVICES AND REFERRALS by DELIVERY CHANNEL Service Provision and Referral Franchise Facilities PSI Direct Service Provision Service Delivery Partner Emergency Contraception Implant Insertion 474, , , ,694,361 1,111,248 Injectables 58,214 43, , ,730 90,638 IUD-IUS Insertion 1,283, , ,817 1,168 2,377,131 1,327,970 Oral Contraceptives 8,111 16,967 50, ,169 25,654 SDM (Cycle Beads) Tubal Ligation 17, , , , ,841 Vasectomy 1,900 3,872 5,772 1,346 Total 1,845,146 1,145,114 2,046,256 1,500 5,038,016 2,754,161 :: SELECTED SERVICES AND REFERRALS PROVIDED by DELIVERY CHANNEL Referral and Service Provision Franchise Facilities CYPs by Delivery Channel (excluding condoms) # Service by Delivery Channel PSI Direct Service Provision Service Delivery Partner Antiretroviral Treatment 45, , ,210 14, ,380 73,321 HIV Testing Services 266, ,086 1,208, ,922,673 55,622 PrEP 1,540 2, , Voluntary Medical Male Circumcision 51,113 96, , ,888 2,293,133 Sexually Transmitted Infection Treatment 13,864 1,444 3, ,430 1,315 TB Treatment 9, ,566 2,036 49, ,908 Fever Cases Tested with RDTs 144,879 1, , ,185 0 Positive RDTs 15, ,255 30,814 0 QAACTs Provided after confirmatory diagnosis 80, ,726 82,804 13,197 Vivax Treatment after confirmatory diagnosis ,808 2, Counseling & Tx for Moderate Acute MalnutritionCU5 0 Treatment for Severe Acute Malnutrition 0 CU5 Treated with DTK after diarrhea dignosis 15,087 15, CU5 Treated with ORS after diarrhea dignosis 1,636 1, CU5 Treated with Zinc after diarrhea dignosis 0 CU5 Treated with antibiotics after pneumonia dignosis 16,381 16,381 7,879 Facility Delivery/Skilled Birth Attendance 16, ,098 23,562 23,169 IPTp2 2,758 78,132 80,890 4,765 Treatment for Pre-Eclampsia (with MgSO4) Safe Abortion & PAC Services 34,041 67, ,236 15,054 Cervical Cancer Screening 85,669 41,796 23, ,292 Cervical Cancer Treatment , Hypertension Screening 258, , , ,319 Hypertension Controlled Condition 68, ,442 Type 2 Diabetes Screening 1,073 4, ,449 Type 2 Diabetes Controlled Condition Referrals Referrals 2018 #Distributed / #Service Target CYPs Provided # Service % 2018 Target Achieved DALYs DALYs Total 1,129, ,713 2,681,348 16,843 4,662,194 2,705,850 IMPACT DASHBOARD - SEPTEMBER